Publication

Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells

Related publications (40)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells

Graph Chatbot

Chat with Graph Search

Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies

Molecular field analysis and 3D-quantitative structure-activity relationship study (MFA 3D-QSAR) unveil novel features of bile acid recognition at TGR5

Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1

In vivo imaging of farnesoid X receptor activity reveals the ileum as the primary bile acid signaling tissue

Nongenomic actions of bile acids. Synthesis and preliminary characterization of 23- and 6,23-alkyl-substituted bile acid derivatives as selective modulators for the G-protein coupled receptor TGR5

Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

The enterohepatic nuclear receptors are major regulators of the enterohepatic circulation of bile salts

Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c

Nuclear receptors and the control of metabolism

Xol INXS: role of the liver X and the farnesol X receptors